Boss of AstraZeneca to step down

The boss of AstraZeneca has announced he is stepping down as the drug maker slashed its full-year profit hopes following a series of patent setbacks.

David Brennan, who has been in the post for six years, will leave on June 1 after coming under fire for not acting sooner to tackle a shortage of blockbuster drugs as patents on existing best sellers expire.